ArticleDiabetes, obesity & metabolism2026

GLP-1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity-Matched Real-World Analysis.

Anastasios Tentolouris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.